Skip to main content
Premium Trial:

Request an Annual Quote

German Ag-Bio Firm Extends License for Biomax Software


NEW YORK (GenomeWeb) – Biomax Informatics said this week that KWS SAAT, a German plant breeding company, has extended an existing software license agreement for Biomax's Pedant-Pro Sequence Analysis suite.

Biomax's software has supported the ag-bio firm's activities around functional and structural annotation of plant and fungal-based genomic and cDNA sequences for several years and is a "central component" of its bioinformatics platform, according to Andreas Menze, KWS' head of bioinformatics. "In addition to the Pedant-Pro system’s broad range of functionality and diverse integrated databases, the software has a very user-friendly GUI, which allows even staff with little IT experience to use the system efficiently," he said in a statement.

Financial and other terms of the renewed agreement were not disclosed.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.